The purpose of this study is to look at whether blockade of the mineralocorticoid receptor
will result in changes in the cardiovascular and inflammatory response to hypoglycemia.
Phase:
N/A
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) National Institutes of Health (NIH) Robert Wood Johnson Foundation